Page last updated: 2024-11-01

nifedipine and Carcinoma, Ehrlich Tumor

nifedipine has been researched along with Carcinoma, Ehrlich Tumor in 3 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Young, RJ1
Smith, TC1
Levinson, C1
Anghileri, LJ1
Thouvenot, P1
Matsuoka, H1
Ueo, H1
Sugimachi, K1
Kai, H1
Matsuura, H1

Other Studies

3 other studies available for nifedipine and Carcinoma, Ehrlich Tumor

ArticleYear
Regulatory volume decrease in Ehrlich ascites tumor cells is not mediated by a rise in intracellular calcium.
    Biochimica et biophysica acta, 1993, Feb-23, Volume: 1146, Issue:1

    Topics: Animals; Calcium; Carcinoma, Ehrlich Tumor; Cell Size; Charybdotoxin; Ionomycin; Male; Mice; Nifedip

1993
ATP in iron overload-induced intracellular calcium changes.
    International journal of molecular medicine, 1998, Volume: 1, Issue:5

    Topics: Adenosine Triphosphate; Animals; Calcium; Calcium Channels; Carcinoma, Ehrlich Tumor; Deferoxamine;

1998
[Calcium antagonist enhances the effect of adriamycin].
    Nihon Geka Gakkai zasshi, 1985, Volume: 86, Issue:4

    Topics: Animals; Calcium Channel Blockers; Carcinoma, Ehrlich Tumor; Doxorubicin; Drug Synergism; Drug Thera

1985